These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27621143)

  • 1. Exploration of the Performance of a Hybrid Closed Loop Insulin Delivery Algorithm That Includes Insulin Delivery Limits Designed to Protect Against Hypoglycemia.
    de Bock M; Dart J; Roy A; Davey R; Soon W; Berthold C; Retterath A; Grosman B; Kurtz N; Davis E; Jones T
    J Diabetes Sci Technol; 2017 Jan; 11(1):68-73. PubMed ID: 27621143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
    Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a Predictive Algorithm in the Prevention of Exercise-Induced Hypoglycemia in Type 1 Diabetes.
    Abraham MB; Davey R; O'Grady MJ; Ly TT; Paramalingam N; Fournier PA; Roy A; Grosman B; Kurtz N; Fairchild JM; King BR; Ambler GR; Cameron F; Jones TW; Davis EA
    Diabetes Technol Ther; 2016 Sep; 18(9):543-50. PubMed ID: 27505305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.
    Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R
    J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.
    Grosman B; Ilany J; Roy A; Kurtz N; Wu D; Parikh N; Voskanyan G; Konvalina N; Mylonas C; Gottlieb R; Kaufman F; Cohen O
    J Diabetes Sci Technol; 2016 May; 10(3):708-13. PubMed ID: 26880389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
    Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manual Closed-Loop Insulin Delivery Using a Saddle Point Model Predictive Control Algorithm: Results of a Crossover Randomized Overnight Study.
    Guilhem I; Penet M; Paillard A; Carpentier M; Esvant A; Lefebvre MA; Poirier JY
    J Diabetes Sci Technol; 2017 Sep; 11(5):1007-1014. PubMed ID: 28677416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of an Overnight Predictive Low-Glucose Suspend System in Relation to Hypoglycemia Risk Factors in Youth and Adults With Type 1 Diabetes.
    Calhoun PM; Buckingham BA; Maahs DM; Hramiak I; Wilson DM; Aye T; Clinton P; Chase P; Messer L; Kollman C; Beck RW; Lum J;
    J Diabetes Sci Technol; 2016 Nov; 10(6):1216-1221. PubMed ID: 27207890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System.
    Abraham MB; de Bock M; Paramalingam N; O'Grady MJ; Ly TT; George C; Roy A; Spital G; Karula S; Heels K; Gebert R; Fairchild JM; King BR; Ambler GR; Cameron F; Davis EA; Jones TW
    Diabetes Technol Ther; 2016 Jul; 18(7):436-43. PubMed ID: 27148807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Glycemic Control and Sleep in Adults with Long-Standing Type 1 Diabetes and Hypoglycemia Unawareness Initiating Hybrid Closed Loop Insulin Delivery.
    Malone SK; Peleckis AJ; Grunin L; Yu G; Jang S; Weimer J; Lee I; Rickels MR; Goel N
    J Diabetes Res; 2021; 2021():6611064. PubMed ID: 33628834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose Control During Physical Activity and Exercise Using Closed Loop Technology in Adults and Adolescents with Type 1 Diabetes.
    Zaharieva DP; Messer LH; Paldus B; O'Neal DN; Maahs DM; Riddell MC
    Can J Diabetes; 2020 Dec; 44(8):740-749. PubMed ID: 33011134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.
    Messer LH; Forlenza GP; Sherr JL; Wadwa RP; Buckingham BA; Weinzimer SA; Maahs DM; Slover RH
    Diabetes Care; 2018 Apr; 41(4):789-796. PubMed ID: 29444895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hybrid Closed-Loop System: Evolution and Practical Applications.
    Weaver KW; Hirsch IB
    Diabetes Technol Ther; 2018 Jun; 20(S2):S216-S223. PubMed ID: 29873517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.
    Garg S; Brazg RL; Bailey TS; Buckingham BA; Slover RH; Klonoff DC; Shin J; Welsh JB; Kaufman FR
    Diabetes Technol Ther; 2012 Mar; 14(3):205-9. PubMed ID: 22316089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of Predictive Low-Glucose Management System in Hybrid of Full Closed Loop System.
    Choudhary P
    Diabetes Technol Ther; 2016 Jul; 18(7):408-9. PubMed ID: 27379979
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management.
    Adams RN; Tanenbaum ML; Hanes SJ; Ambrosino JM; Ly TT; Maahs DM; Naranjo D; Walders-Abramson N; Weinzimer SA; Buckingham BA; Hood KK
    Diabetes Technol Ther; 2018 Oct; 20(10):648-653. PubMed ID: 30239219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.